1 cardiac toxicity assessments supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.
InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process using patient-derived and gene-edited human samples, including an automated, scalable, functional 3D engineered micro-human heart tissue platform. It integrates cell and tissue handling automation, tissue phenotyping assays, computational biology (AI), and human organ/tissue data to identify safety and efficacy profiles of treatments. Founded in 2001 in St. Louis, Missouri, with technology licensed from Washington University, and moved to Wisconsin in 20
3D engineered micro-human heart tissueautomated cell and tissue handlingbiomechanical assayscompound screeningcomputational biology/AIgene editinghigh-throughput phenotypinginduced pluripotent stem cell (iPSC) technologyoptical devices
Related capabilities
Other processes offered by the shops that list cardiac toxicity assessments.
